Alseres Pharmaceuticals
(OTC) ALSE
This security has been delisted. This page is retained for historical reference.
ALSE News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowALSE Financials
Key Financial Metrics (TTM)
Gross Margin
95%
Operating Margin
-2%
Net Income Margin
-2%
Return on Equity
5%
Return on Capital
77%
Return on Assets
-2%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$450.04K
Operating Income
$970.00K
EBITDA
$486.00K
Operating Cash Flow
$1.69M
Capital Expenditure
$0.00
Free Cash Flow
$1.69M
Cash & ST Invst.
$320.96K
Total Debt
$7.82M
Alseres Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$18.43K
+0.0%
Gross Profit
$17.51K
-5.0%
Gross Margin
95.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
3
N/A
Net Income
$321.00K
+38.3%
EBITDA
$317.12K
+22.5%
Quarterly Fundamentals
Net Cash
$8.22M
-28.3%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$8.30M
N/A
Short Term Debt
$118.86K
-98.2%
Return on Assets
-2.44%
N/A
Return on Invested Capital
76.81%
N/A
Free Cash Flow
$272.06K
+9.2%
Operating Cash Flow
$272.06K
+9.2%